Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$524M |
| 2 |
Peloton Interactive
PTON
|
+$465M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$290M |
| 5 |
Snap
SNAP
|
+$262M |
Top Sells
| 1 |
Zoom
ZM
|
+$965M |
| 2 |
Pinduoduo
PDD
|
+$805M |
| 3 |
AbbVie
ABBV
|
+$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.18% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Quest Resource Holding
QRHC
$32.3M
| $864K | ﹤0.01% |
373,987
+62,795
| +20% | +$145K |
|
2577
Amalgamated Financial
AMAL
$837M
| $861K | ﹤0.01% |
62,700
+38,734
| +162% | +$532K |
|
|
JG
2578
Aurora Mobile
JG
$56.7M
| $861K | ﹤0.01% |
12,096
-529
| -4% | -$37.7K |
|
2579
Farmmi
FAMI
$2.6M
| $858K | ﹤0.01% |
298
+143
| +92% | +$412K |
|
2580
Cue Biopharma
CUE
$55.5M
| $854K | ﹤0.01% |
68,300
-55,196
| -45% | -$690K |
|
2581
Evolus
EOLS
$422M
| $852K | ﹤0.01% |
253,648
+171,499
| +209% | +$576K |
|
2582
Light & Wonder
LNW
$7.4B
| $851K | ﹤0.01% |
+20,500
| New | +$851K |
|
|
CYRN
2583
DELISTED
CYREN Ltd.
CYRN
| $851K | ﹤0.01% |
41,319
+2,190
| +6% | +$45.1K |
|
|
MITO
2584
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $849K | ﹤0.01% |
568,164
+478,903
| +537% | +$716K |
|
2585
Electro-Sensors
ELSE
$16.3M
| $845K | ﹤0.01% |
175,700
+66,900
| +61% | +$322K |
|
2586
Alerian MLP ETF
AMLP
$10.5B
| $844K | ﹤0.01% |
+32,900
| New | +$844K |
|
|
RTL
2587
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $844K | ﹤0.01% |
113,533
-73,200
| -39% | -$544K |
|
2588
ClearPoint Neuro
CLPT
$303M
| $843K | ﹤0.01% |
53,048
+11,100
| +26% | +$176K |
|
2589
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.71B
| $843K | ﹤0.01% |
+14,400
| New | +$843K |
|
2590
Euroseas
ESEA
$445M
| $842K | ﹤0.01% |
190,627
+147,358
| +341% | +$651K |
|
2591
First Internet Bancorp
INBK
$210M
| $842K | ﹤0.01% |
29,300
+15,900
| +119% | +$457K |
|
2592
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $841K | ﹤0.01% |
5,283
+2,583
| +96% | +$411K |
|
2593
First Western Financial
MYFW
$221M
| $840K | ﹤0.01% |
42,900
+26,585
| +163% | +$521K |
|
2594
INNOVATE Corp
VATE
$63.3M
| $840K | ﹤0.01% |
25,760
+8,380
| +48% | +$273K |
|
|
FURY
2595
Fury Gold Mines
FURY
$116M
| $839K | ﹤0.01% |
582,746
+336,978
| +137% | +$485K |
|
|
RUHN
2596
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
| $839K | ﹤0.01% |
287,268
+113,968
| +66% | +$333K |
|
2597
Invesco Taxable Municipal Bond ETF
BAB
$925M
| $838K | ﹤0.01% |
25,009
+6,109
| +32% | +$205K |
|
2598
Clear Channel Outdoor Holdings
CCO
$691M
| $832K | ﹤0.01% |
+504,210
| New | +$832K |
|
2599
PDF Solutions
PDFS
$792M
| $832K | ﹤0.01% |
38,500
-15,800
| -29% | -$341K |
|
|
NBRV
2600
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $829K | ﹤0.01% |
13,694
+13,572
| +11,125% | +$822K |
|